Dr. M. Cristina Vega leads a research group at the Chemical and Structural Biology Department, part of the Center for Biological Research Margarita Salas (CIB-CSIC) in Madrid, Spain. Her research blends biochemical, biophysical, and structural biology techniques to explore the mechanisms by which pathogens circumvent the human complement system and other immune defenses and to develop innovative diagnostic and therapeutic approaches. Dr. Francisco J. Fernández, as the CEO of Abvance Biotech SL, a cutting-edge biopharmaceutical company in Madrid, Spain, brings his extensive expertise in structural biology and recombinant protein production and characterization to the forefront. His work is distinguished by a profound interest in applying synthetic and computational biology tools and techniques for therapeutic antibody development. Dr. Fernández’s innovative approach in these fields underpins his leadership in advancing biotechnological applications in medicine.